New CBER Guidance, Posted 9 January 2002

January 18, 2002
BioPharm International Editors

Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products

Related Content:

News